Symbol="GERN"
AssetType="Common Stock"
Name="Geron Corporation"
Description="Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California."
CIK="886744"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="149 COMMONWEALTH DRIVE, SUITE 2070, MENLO PARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="1597528000"
EBITDA="-149636992"
PERatio="None"
PEGRatio="-2.38"
BookValue="0.641"
DividendPerShare="0"
DividendYield="0"
EPS="-0.35"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-303.58"
ReturnOnAssetsTTM="-0.301"
ReturnOnEquityTTM="-0.708"
RevenueTTM="494000"
GrossProfitTTM="-93668000"
DilutedEPSTTM="-0.35"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.829"
AnalystTargetPrice="4.83"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="571.98"
PriceToBookRatio="8.28"
EVToRevenue="493.55"
EVToEBITDA="-6.08"
Beta="0.863"
num_52WeekHigh="3.84"
num_52WeekLow="1.72"
num_50DayMovingAverage="3.108"
num_200DayMovingAverage="2.645"
SharesOutstanding="508767000"
DividendDate="None"
ExDividendDate="None"
symbol="GERN"
open="3.18"
high="3.21"
low="3.12"
price="3.14"
volume="2690825.00"
latest_trading_day="2023-07-11"
previous_close="3.20"
change="-0.06"
change_percent="-1.8750%"
aroon_positive_momentum_days="71"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="71"
Volume_recent_avg="6043360"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="71"
Aroon_momentum_negative="29"
image_negative_thumbnail_id_1="1123"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_negative_thumbnail_id_2="1106"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0139.jpeg"
image_neutral_thumbnail_id_1="562"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0037.jpeg"
image_neutral_thumbnail_id_2="573"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="1009"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0171.jpeg"
image_professor_thumbnail_id_1="1174"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0008.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
